OCGNVSRARE• 3 Months (Normalized)
OCGN vs RARE (Ocugen Inc. vs Ultragenyx Pharmaceutical Inc.)
Showing Closing Date Range from Jun, 19 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
OCGN Performance $1.03
-20.16%
Ocugen Inc.
Normalized Baseline0.00%
RARE Performance $14.5
-50.05%
Ultragenyx Pharmaceutical Inc.
Normalized Baseline0.00%
Alpha Spread Margin OCGN LEADS
+29.89%
OCGN outperforming by 29.89%
OCGNRARE
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
OCGN RARE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | OCGN Price | OCGN Gain (%) | RARE Price | RARE Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $1.03 | -20.16% | $14.50 | -50.05% | +29.89% |
| Sep 16, 2026 | $1.00 | -22.64% | $12.88 | -55.63% | +32.99% |
| Sep 15, 2026 | $0.99 | -22.95% | $13.07 | -54.98% | +32.03% |
| Sep 14, 2026 | $1.06 | -17.83% | $13.61 | -53.12% | +35.29% |
| Sep 11, 2026 | $1.02 | -20.93% | $14.30 | -50.74% | +29.81% |
| Sep 10, 2026 | $1.03 | -20.54% | $14.40 | -50.40% | +29.86% |
| Sep 09, 2026 | $1.07 | -17.44% | $14.31 | -50.71% | +33.27% |
| Sep 08, 2026 | $1.33 | +3.10% | $14.88 | -48.74% | +51.84% |
| Sep 04, 2026 | $1.36 | +5.43% | $15.30 | -47.30% | +52.73% |
| Sep 03, 2026 | $1.35 | +4.65% | $14.85 | -48.85% | +53.50% |
| Sep 02, 2026 | $1.32 | +2.33% | $26.53 | -8.61% | +10.94% |
| Sep 01, 2026 | $1.33 | +3.10% | $25.81 | -11.09% | +14.19% |
| Aug 31, 2026 | $1.33 | +3.10% | $25.21 | -13.16% | +16.26% |
| Aug 28, 2026 | $1.32 | +2.33% | $25.61 | -11.78% | +14.11% |
| Aug 27, 2026 | $1.37 | +6.20% | $26.26 | -9.54% | +15.74% |
Page 1 of 5